Epiretinal implant scientists awarded

Article

Scientists who produced a visual prosthesis giving rudimentary sight to the blind are to receive the Joseph von Fraunhofer Prize 2008 in recognition of their achievement.

Scientists who produced a visual prosthesis giving rudimentary sight to the blind are to receive the Joseph von Fraunhofer Prize 2008 in recognition of their achievement. The Joseph von Fraunhofer Prize is awarded annually to acknowledge outstanding scientific achievements in solving application-related problems.

Dr Ingo Krisch, Dipl-Ing Michael Görtz and Dr Hoc Khiem Trieu of the Fraunhofer Institute for Microelectronic Circuits and Systems IMS share the award, worth €20 000, for the wireless implantable chip, which has enabled patients blinded by retinal disease to perceive light spots and geometric patterns. The Epi-Ret epiretinal implant chip, the product of 12 years' labour, was unveiled in September 2007 following clinical trials on six patients.

The German Ministry of Education and Research funded the research to develop the chip. EPI-RET GmbH, a joint venture company spun off from the research, plans to continue trials and market a version of the implant in approximately three years' time.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.